Virpas Tablets

Medicine Detail

Brand Name: Virpas tablets 
Composition: Ledipasvir and Sofosbuvir 
Strength: Ledipasvir 90 mg and Sofosbuvir 400mg 
Manufactured by: Strides Shasun 
Packing: Pack of 28 tablets


Virpas Tablets is mix of two hepatitis C infection (HCV) antiviral medications in a solitary shape. Each single tablet contains ledipasvir 90mg and sofosbuvir 400 mg. 


It is a mix of ledipasvir and sofosbuvir and is utilized to treat endless (durable) hepatitis C, a viral contamination of the liver. It might once in a while be utilized with another antiviral pharmaceutical (ribavirin). These medications work by decreasing the measure of hepatitis C infection in your body, which enables your resistant framework to battle the contamination and may enable your liver to recuperate. 


Tiredness, cerebral pain, sickness, loose bowels, or trouble resting may happen. In the event that any of these impacts hold on or compound, tell your specialist or drug specialist expeditiously. 


An intense unfavorably susceptible response to this medication is uncommon. In any case, get restorative help immediately on the off chance that you see any manifestations of a genuine hypersensitive response, including: rash, tingling/swelling (particularly of the face/tongue/throat), serious dazedness, inconvenience relaxing. 


Take this drug in the dosage and span as exhorted by your specialist. Gulp down it as an entire. Try not to bite, squash or break it. Virpas 90 mg/400mg Tablet might be taken with or without sustenance, yet it is smarter to require it at a settled investment. 

Virpas 90 mg/400mg Tablet is a blend of two antiviral prescriptions: Ledipasvir and Sofosbuvir. They work by bringing down the measure of hepatitis C infection in the body and expelling the infection from the blood over some stretch of time. 


Virpas 90 mg/400mg Tablet is most likely safe to use amid lactation. Constrained human information proposes that the medication does not speak to a critical hazard to the infant. 

Virpas 90 mg/400mg Tablet ought to be utilized with alert in patients with serious kidney illness. Dosage modification of Virpas 90 mg/400mg Tablet might be required. If it's not too much trouble counsel your specialist. 

Constrained data is accessible on utilization of Virpas 90 mg/400mg Tablet in these patients. No measurements alteration is prescribed in patients with mellow to direct kidney illness. 

Try not to drive except if you are feeling admirably. 

Virpas 90 mg/400mg Tablet, when taken together with different pharmaceuticals for the treatment of hepatitis c disease, may deliver unsteadiness, obscured vision and this may influence your capacity to drive.

Write a review

Note: HTML is not translated!
    Bad           Good